PPD Continues High-speed Expansion In Asia
This article was originally published in The Pink Sheet Daily
U.S.-based CRO makes its second acquisition this quarter of a Chinese CRO.
You may also be interested in...
BEIJING - The financial crisis ricocheting across the United States and Europe could cut into R&D funding by the globe's top pharmaceutical powers, but is also likely to trigger sending more drug research to Chinese scientists, according to industry insiders and analysts
Excel PharmaStudies Chairman Mark Engel On China’s Rapidly Expanding Clinical Trials: An Interview With PharmAsia News (Part 1 of 2)
BEIJING - Excel PharmaStudies, established in 2000, is one of the leading clinical research organizations in China. Excel PharmaStudies Chairman Mark Engel recently talked with PharmAsia News' Beijing bureau about the high-speed development of China's pharmaceutical market and the role of clinical trials in China. Engel also outlined challenges, solutions and opportunities regarding clinical trials in China.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.